tuneTypical Dose
3200 mg to 6400 mg
Amino Acid
Beta-Alanine
3-aminopropionic acid
Evidence TierBWADA NOT PROHIBITED
watchEffect Window
Likely at 4-8 weeks with consistent intake. Stronger with continued protocol adherence.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Clinical Summary
Beta-alanine raises muscle carnosine and has its best evidence for repeated high-intensity efforts lasting about 30 seconds to 10 minutes.
Beta-alanine is one of the better-supported performance supplements, but its use case is narrower than general “endurance” marketing suggests. The most reliable benefit is improved buffering during hard efforts that accumulate substantial acidosis, especially capacity-style exercise and repeated intervals. Evidence for very short sprint performance, cognition, or general wellness remains weak. Functional benefits in older adults are promising but still secondary, and paresthesia is a tolerability issue rather than an efficacy marker.
Beta-alanine increases carnosine availability and can improve exercise pH buffering capacity in selected high-intensity efforts.
Outcomes
What This Is Expected To Influence
Primary Outcomes
- Higher likelihood of improved exercise capacity in selected high-intensity protocols.
Secondary Outcomes
- No reliable evidence for broad cognition/mood enhancement in general healthy populations.
Safety
Contraindications and Interactions
Contraindications
- Pregnancy (caution)
- Lactation (caution)
- Severe cardiovascular risk
- Severe psychiatric disease
- Active unstable endocrine, renal, or hepatic disease
Side effects
- Dose-dependent paresthesia/tingling. Bolus doses around 40 mg/kg or higher are most likely to be uncomfortable.
- Mild GI distress
Interactions
- Blood-glucose-lowering drugs (Theoretical/Unknown) - Possible additive glucose-lowering effect. Monitor for hypoglycemia symptoms.
- Blood-glucose-lowering supplements (Theoretical/Unknown) - Possible additive glucose-lowering effect. Monitor for hypoglycemia symptoms.
- Hepatotoxic drugs (Theoretical/Unknown) - Potential overlap in liver stress. Use clinician oversight if combined.
- Hepatotoxic supplements (Theoretical/Unknown) - Potential overlap in liver stress. Use clinician oversight if combined.
- Drugs that can raise sodium (Theoretical/Unknown) - Possible additive hypernatremia risk in susceptible users.
- Supplements that can raise sodium (Theoretical/Unknown) - Possible additive hypernatremia risk in susceptible users.
- High-risk CNS/stimulant multi-ingredient blends - Limited direct interaction evidence. Use caution until individual response is known.
Avoid if
- Pregnancy considerations
- Lactation considerations
- Active unstable disease
- Active malignancy unless oncology clinician approves use
- High-risk medication burden
- Known ingredient sensitivities
- Unverified supplement sources
Evidence
Study-level References
beta-alanine-SRC-001Position statement review.
Sourceopen_in_newTrexler ET et al. International society of sports nutrition position stand: Beta-Alanine. J Int Soc Sports Nutr. 2015;12:30. DOI: 10.1186/s12970-015-0090-y.
Population: Human trials across exercise and supplementation contexts reviewed, including loading doses around 4-6 g/day.
Key findings: Supports performance mechanism and recommends split doses/sustained-release to reduce paresthesia. Practical dosing aligned with 4-6 g/day loading in many studies.
Notes: Narrative synthesis. Not a primary-effect quantitative dataset.
Paper content
Supports performance mechanism and recommends split doses/sustained-release to reduce paresthesia; practical dosing aligned with 4-6 g/day loading in many studies.
beta-alanine-SRC-002PRISMA-based meta-analysis.
Sourceopen_in_newSaunders B et al. Beta-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med. 2017;51(8):658-669. PMID: 27797728. DOI: 10.1136/bjsports-2016-096396.
Population: 40 studies, 1461 participants, 65 exercise protocols, healthy populations.
Key findings: Direction favorable for exercise capacity/performance in targeted time windows. Reported effect size around 0.18 overall, stronger in 0.5-10 min capacity tests.
Notes: Heterogeneous protocols/doses. Pooled results may overrepresent certain training contexts.
Paper content
Direction favorable for exercise capacity/performance in targeted time windows; reported effect size around 0.18 overall, stronger in 0.5-10 min capacity tests.
beta-alanine-SRC-003Meta-analysis.
Sourceopen_in_newEffects of beta-alanine supplementation on exercise performance: a meta-analysis. Meta-analysis. PMID: 22270875. DOI: 10.1007/s00726-011-1200-z.
Population: 360 participants, 23 exercise tests, mixed healthy adult protocols.
Key findings: Supports benefit in 60-240 s and >240 s efforts. Little to no benefit in <60 s efforts. Median pooled gain ~2.85%.
Notes: Older pooled literature with variable protocol quality and dose reporting.
Paper content
Supports benefit in 60-240 s and >240 s efforts; little to no benefit in <60 s efforts; median pooled gain ~2.85%.
beta-alanine-SRC-004Regulatory safety risk assessment.
Sourceopen_in_newLøvik M et al. Risk Assessment of "Other Substances": Beta-Alanine. Eur J Nutr Food Safety. 2018;8(4):336-338. DOI: 10.9734/EJNFS/2018/44970.
Population: Adults exposed to 1000-2000 mg/day scenarios with referenced clinical studies.
Key findings: Main adverse effect is transient paresthesia. No major clinical toxicity signal in reviewed short-duration studies.
Notes: Not efficacy-focused. Long-term human adverse-event data limited.
Paper content
Main adverse effect is transient paresthesia; no major clinical toxicity signal in reviewed short-duration studies.
beta-alanine-SRC-005Randomized controlled trial.
Sourceopen_in_newFurst T et al. Beta-alanine supplementation increased physical performance and improved executive function following endurance exercise in middle aged individuals. J Int Soc Sports Nutr. 2018;15:39. DOI: 10.1186/s12970-018-0238-7. PMID: 29996843.
Population: Healthy middle-aged adults (n=12), 2.4 g/day for 28 days.
Key findings: Small positive capacity finding. Exploratory executive-function signal in a small, narrow sample.
Notes: Very small sample and limited external validity.
Paper content
Small positive capacity finding; exploratory executive-function signal in a small, narrow sample.
beta-alanine-SRC-006Double-blind randomized controlled trial.
Sourceopen_in_newOstfeld I et al. Role of beta-alanine supplementation on cognitive function, mood, and physical function in older adults. Nutrients. 2023;15(4):923. DOI: 10.3390/nu15040923. PMID: 36839281.
Population: Older adults (n=100), 2.4 g/day for 10 weeks.
Key findings: Mixed cognitive and mood outcomes. Not robust enough to support broad nootropic claims.
Notes: Emerging age-specific trial. Outcomes were secondary in many cases.
Paper content
Mixed cognitive and mood outcomes; not robust enough to support broad nootropic claims.
beta-alanine-SRC-007Official regulatory guideline.
Sourceopen_in_newWorld Anti-Doping Agency Prohibited List landing page: https://www.wada-ama.org/en/content/what-is-prohibited (official).
Population: Universal for listed substances/methods with periodic annual updates.
Key findings: Beta-alanine not explicitly identified as a separate prohibited ingredient in current summaries. Contamination and product-level risk still applies.
Notes: Not a clinical source. Requires explicit in-season verification and lot-level supplement screening.
Paper content
Beta-alanine not explicitly identified as a separate prohibited ingredient in current summaries; contamination and product-level risk still applies.
beta-alanine-SRC-008Systematic review and meta-analysis
Sourceopen_in_newde Camargo JBB, Brigatto FA. Beta-Alanine for Improving Exercise Capacity, Muscle Strength, and Functional Performance of Older Adults: A Systematic Review. J Aging Phys Act. 2025;33(4):399-407. doi:10.1123/japa.2024-0118. PMID:39724872.
Population: Older adults across five beta-alanine supplementation studies.
Dose protocol: Chronic oral loading protocols in middle-aged and older adults.
Key findings: Updated review suggested selected physical-performance benefits in middle-aged and older adults, while cognition and body-composition outcomes remained inconsistent.
Notes: Supports the current "minority functional improvement" framing without expanding nootropic claims.
Paper content
Updated review suggested beta-alanine can improve selected physical-performance outcomes in middle-aged and older adults, while evidence for cognition and body composition remained less consistent.
beta-alanine-SRC-009Systematic review and meta-analysis of randomized, double-blinded, placebo-controlled trials
Sourceopen_in_newGeorgiou GD, Antoniou K, Antoniou S, Michelekaki EA, Zare R, Ali Redha A, Prokopidis K, Christodoulides E, Clifford T. Effect of Beta-Alanine Supplementation on Maximal Intensity Exercise in Trained Young Male Individuals: A Systematic Review and Meta-Analysis. Int J Sport Nutr Exerc Metab. 2024;34(6):397-412. doi:10.1123/ijsnem.2024-0027. PMID:39032921.
Population: Trained male individuals aged 18 to 40 years from 18 included studies.
Dose protocol: Chronic beta-alanine supplementation in trained young males across 18 double-blinded placebo-controlled RCTs (n=331).
Key findings: Significant ergogenic effect (ES 0.39, p=0.01) for maximal intensity exercise. Greatest benefits at 5.6 to 6.4 g per day, after 4 weeks of loading, and during 4 to 10 minute efforts.
Notes: Most population-specific meta-analysis to date, narrowing protocol recommendations for trained males.
Paper content
This systematic review and meta-analysis of 18 RCTs with 331 trained young males found a significant overall ergogenic effect of chronic beta-alanine supplementation on maximal intensity exercise (effect size 0.39, p=0.01). The greatest benefits were observed at 4 weeks of supplementation, during 4 to 10 minute maximal efforts, and with daily dosages of 5.6 to 6.4 g. The results help clarify which exercise modalities and supplementation protocols yield the greatest performance gains.